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Downregulation of E2F1 during ER stress is required to induce
apoptosis
Vittoria Pagliarini1,*,`, Paola Giglio1, Paolo Bernardoni1, Daniela De Zio2,3, Gian Maria Fimia1,4,
Mauro Piacentini1,5 and Marco Corazzari1,5,§
ABSTRACT
The endoplasmic reticulum (ER) has recently emerged as an
alternative target to induce cell death in tumours, because
prolonged ER stress results in the induction of apoptosis even in
chemoresistant transformed cells. Here, we show that the DNA-
damage-responsive pro-apoptotic factor E2F1 is unexpectedly
downregulated during the ER stress-mediated apoptotic
programme. E2F1 decline is a late event during the ER response
and is mediated by the two unfolded protein response (UPR) sensors
ATF6 and IRE1 (also known as ERN1). Whereas ATF6 directly
interacts with the E2F1 promoter, IRE1 requires the involvement of
the known E2F1 modulator E2F7, through the activation of its main
target Xbp-1. Importantly, inhibition of the E2F1 decrease prevents
ER-stress-induced apoptosis, whereas E2F1 knockdown efficiently
sensitises cells to ER stress-dependent apoptosis, leading to the
upregulation of two main factors in the UPR pro-apoptotic execution
phase, Puma and Noxa (also known as BBC3 and PMAIP1,
respectively). Our results point to a novel key role of E2F1 in the
cell survival/death decision under ER stress, and unveil E2F1
inactivation as a valuable novel potential therapeutic strategy to
increase the response of tumour cells to ER stress-based anticancer
treatments.
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INTRODUCTION
Cancer refers to a large number of diseases characterised by the
development of abnormal cells that divide in an uncontrollable
manner and have the ability to escape cell death programmes.
Multiple cancer-related genomic alterations that drive unrestrained
cell proliferation bypass many checkpoints controlling cell cycle,
DNA repair, differentiation and apoptosis. Thus, abnormalities
in the apoptotic machinery often occur in tumours, causing a
chemotherapy-resistant phenotype of transformed cells. DNA
damage, together with intrinsic and extrinsic apoptotic pathways,
have represented the main targets for clinical cancer therapy so far.
In recent years, the endoplasmic reticulum (ER) has been
extensively studied as an alternative opportunity to induce cancer
cell death (Boelens et al., 2007; Corazzari et al., 2007). The ER
compartment contributes to overall intracellular Ca2+ storage and is
responsible for the folding of transmembrane, secretory and ER-
resident proteins, and post-transcriptional protein modifications
(Helenius, 1994). Many intra- and extracellular stimuli result in
imbalance of the ER functions, causing the accumulation of
unfolded or misfolded proteins and protein aggregates that are
detrimental to cell survival, a state termed ‘ER stress’. Eukaryotic
cells have evolved an adaptive response to ER stress, commonly
termed the unfolded protein response (UPR), consisting of: (1)
general protein translation attenuation, (2) upregulation of ER-
resident chaperones and (3) activation of a degradative pathway
(ER-associated degradation – ERAD) to eliminate unfolded
proteins by proteasomal degradation. All these activities are
orchestrated by the cooperative action of three ER transmembrane
proteins acting as stress sensors – PERK (also known as
EIF2AK3), ATF6 and IRE1 (also known as ERN1), together
with the ER-resident main chaperone GRP78 (also known as Bip).
The aim of the ER stress response is to reduce the stress and
thereby restore the folding capacity of this apparatus (Rutkowski
and Kaufman, 2004). Although the UPR is generally viewed as a
cytoprotective response, prolonged ER stress can activate cell
death through both mitochondrial-dependent and -independent
pathways (Breckenridge et al., 2003; Rao et al., 2002).
The Bcl-2 protein family plays a pivotal role in the regulation
of cell death, including during ER-stress-mediated apoptosis.
More than 20 members with either pro-apoptotic or anti-apoptotic
functions are part of the family. In particular, members of the
BH3-only subgroup inhibit the anti-apoptotic and activate the
pro-apoptotic members of the family to induce cell death. Recent
evidence supports an involvement of Bcl-2 family members in the
maintenance of ER homeostasis and in stress signal transduction
pathways, with the BH3-only proteins Bim, Puma and Noxa (also
known as BCL2L11, BBC3 and PMAIP1, respectively) playing a
pivotal role in ER-stress-mediated apoptosis (Li et al., 2006;
Puthalakath et al., 2007; Reimertz et al., 2003). Several reports
also support the hypothesis of an involvement of the transcription
factor E2F1 in the regulation of both Puma and Noxa during the
execution of the ER stress programme, but the molecular
mechanism is still largely unclear (Futami et al., 2005; Park
et al., 2006).
E2F1 belongs to the E2F family of transcription factors, which
is composed of at least eight members that can be divided into
two distinct subgroups of activators and repressors, on the basis
of their structural and functional similarities (DeGregori and
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Fig. 1. See next page for legend.
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Johnson, 2006). The E2F transcription factors modulate
progression through the cell cycle by regulating the expression
of genes required in the G1 to S phase transition (Dyson, 1998). A
large number of studies clearly support the role of E2F1 and other
family members as both tumour promoters and suppressors. It is
now clear that this bifunctional role appears to be linked to the
cell context as well as to the presence and the activity of other
members of the E2F family and the E2F-interacting tumour
suppressor pRb (Tsantoulis and Gorgoulis, 2005). E2F1 plays a
key role in DNA-damage-induced apoptosis in a p53-dependent
and -independent manner (Bates et al., 1998; Hiebert et al., 1995).
However, it is still unclear whether E2F1 is involved in other
stress signalling pathways, including ER stress.
In the present work, we demonstrate that upregulation of Puma
and Noxa is strictly required for the apoptotic execution phase of
ER stress. The early upregulation of both proteins is dependent on
ATF4 activity, whereas late downregulation of E2F1 during the
UPR is required to sustain the expression of both the BH3-only
proteins, regulating the life/death switch during prolonged ER
stress response. Moreover, we identified ATF6 and E2F7 as the
key regulators of UPR-mediated E2F1 downregulation.
RESULTS
ER stress-induced apoptosis is mediated by ATF4-dependent
upregulation of Puma and Noxa and by E2F1 downregulation
Although the role of the BH3-only proteins Puma and Noxa in
the ER-stress-mediated apoptotic pathway is well known, the
molecular mechanisms controlling the expression of such factors
under conditions of ER stress remain only partially elucidated. To
address this issue, we induced ER stress-mediated apoptosis in
the human fibrosarcoma cell line 2FTGH (hereafter referred to as
2F cells), by using two well-known inducing agents –
thapsigargin and tunicamycin (Kass and Orrenius, 1999)
(Fig. 1A), and confirmed the upregulation of both Puma and
Noxa in a time-dependent manner (Fig. 1B).
Next, 2F cells were transiently transfected with specific small
interfering (si)RNA oligos for both factors (Fig. 1C) and cells
were exposed to thapsigargin (24 h). Apoptotic rates evaluated
with respect to control-siRNA-treated (siCtrl) cells revealed that
the absence of the two proteins resulted in the inhibition of ER-
stress-mediated apoptosis, indicating that both Puma and Noxa
are required for the execution of ER-stress-mediated apoptosis
(Fig. 1D).
To confirm the involvement of ATF4 in the ER stress-mediated
upregulation of these BH3-only proteins (Armstrong et al., 2010;
Galehdar et al., 2010; Qing et al., 2012), the expression of ATF4
was inhibited by transiently transfecting specific siRNA oligos into
2F cells (Fig. 1E), and the transcriptional levels of both Noxa and
Puma were analysed upon thapsigargin treatment (4 h) in
comparison to those of siCtrl cells. As reported in Fig. 1F,G, the
expression of both factors was abrogated when thapsigargin-
mediated ATF4 upregulation was inhibited. Moreover, the
inhibition of ATF4 expression also resulted in decreased
apoptosis induction after thapsigargin treatment, compared with
that of control (Fig. 1H), confirming an active role of this
transcription factor in the ER-stress-mediated cell death pathway.
Because E2F1 regulates the expression of BH3-only proteins
under DNA-damage-induced apoptosis (Hershko and Ginsberg,
2004), we asked whether it could also contribute to the regulation
of Noxa and Puma during the UPR. To test this hypothesis, we
evaluated E2F1 mRNA and protein levels in 2F cells after 4, 8
and 18 h of thapsigargin and tunicamycin treatment, using
etoposide as a non-ER stress-mediated stimulator of apoptosis.
Unexpectedly, there was a significant decrease in E2F1 mRNA
and protein levels between 8 and 18 h of thapsigargin or
tunicamycin treatment (Fig. 1I, lower panel; Fig. 1J). By
contrast, etoposide treatment promoted an upregulation of E2F1
(Fig. 1I, upper panel), suggesting that this downregulation
represents a specific feature of the ER stress response.
Downregulation of E2F1 under ER stress conditions was, in
fact, confirmed in other cells, such as CHL-1 melanoma and
SaOS-2 osteosarcoma cell lines, after an 18-h exposure to
thapsigargin or tunicamycin (Fig. 1K).
In parallel, we evaluated the expression of the other two
members of the same E2F1 subgroup of the E2F family, E2F2
and E2F3. Thapsigargin treatment only marginally affected the
expression of these transcription factors, indicating that E2F1 is a
specific target of ER stress among the E2F1 subgroup family
members and also excluding compensatory effects by E2F2 and
E2F3 during ER stress-induced apoptosis (Fig. 1L). Collectively,
these data suggest that ER perturbation leading to activation of
the UPR and cell death results in E2F1 downregulation due to its
transcriptional repression.
Downregulation of E2F1 increases ER stress-mediated
apoptosis
In order to evaluate whether E2F1 downregulation represents a
key event for the induction of ER stress-mediated apoptosis or
merely represents a consequence of ER stress or apoptosis
induction, we tested whether the absence of E2F1 affects the
apoptotic outcome induced by ER stress. To this end, we
downregulated the expression of E2F1 by RNA interference
(RNAi) and assessed the rate of cell death after the induction of
Fig. 1. ER stress-mediated apoptosis results in ATF4-mediated early
expression of Puma and Noxa, and late downregulation of E2F1.
(A) Flow cytometric analysis of propidium-iodide-stained 2F cells incubated
with thapsigargin (TG) or tunicamycin (TN), as indicated, shows increased
cell death induction in a time-dependent manner. (B) Western blotting
analysis shows the upregulation of Puma and Noxa protein levels in a time-
dependent manner in 2F cells treated as in A. Gapdh is shown as a protein
loading control in all blots. All western blotting data are representative of
experiments performed three times. (C) 2F cells were transiently co-
transfected with specific oligos for Noxa (siNoxa) and Puma (siPuma), and
the expression of both factors was evaluated by qRT-PCR. r.l., relative levels.
(D) 2F siCtrl and siNoxa/Puma cells were exposed to thapsigargin (24 h),
and flow cytometric analysis of propidium-iodide-stained cells shows a
decreased apoptosis induction in cells lacking both Noxa and Puma factors.
(E) 2F cells were transiently transfected with specific oligos for ATF4
(siATF4#5; siATF4#9) and the expression of ATF4 was evaluated by qRT-
PCR, confirming a specific downregulation of ATF4. Scrambled oligo was
used as a negative control (siCtrl). (F,G) Cells in E were treated for 4 h with
thapsigargin or left untreated, and the expression of Noxa (F) or Puma
(G) was evaluated by qRT-PCR, revealing impaired thapsigargin-mediated
early upregulation of both factors in the absence of ATF4. (H) 2F siCtrl and
siATF4 cells were treated with thapsigargin and the induction of apoptosis
was evaluated at 24 h post-treatment, revealing a decreased cell sensitivity
to cell death induction in the absence of ATF4. (I,J) Western blotting (I) and
qRT-PCR (J) analysis of E2F1 expression of 2F cells treated with
thapsigargin, tunicamycin or etoposide (Eto), as indicated, shows a clear
downregulation of E2F1 under ER stress conditions. (K) E2F1 protein levels
were evaluated in melanoma CHL-1 and osteosarcoma SaOS-2 cells treated
with thapsigargin or tunicamycin for 24 h or left untreated, by western blotting
analysis, confirming data reported in I. (L) The expression of E2F1, E2F2 and
E2F3 was evaluated in 2F cells treated or untreated with thapsigargin, as
indicated, by qRT-PCR. All quantitative data show the mean6s.d. and are
representative of three independent experiments performed in triplicate.
*P,0.05, #P,0.05 (Student’s t-test).
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ER stress. E2F1-specific siRNA oligonucleotides (siE2F1) were
transiently transfected into 2F or SaOS-2 cells, and E2F1
expression was evaluated by measuring either protein or mRNA
levels by western blotting or quantitative (q)RT-PCR analysis,
respectively. Two independent siE2F1 oligos efficiently
abrogated the expression of target protein (.75%), in both 2F
and SaOS-2 cell lines (Fig. 2A,C). Then, 2F and SaOS-2 cells
transiently transfected with control siRNA and siE2F1 (#1 or #2)
were exposed to thapsigargin for 24 h, and cell death was
quantitatively assessed by measuring the sub-G1 cell population
of propidium-iodide-stained cells by flow cytometry.
Interestingly, E2F1 downregulation significantly increased the
apoptotic rate of both cell lines in response to thapsigargin
exposure compared to that of control, whereas basal cell viability
was not affected (Fig. 2B,D).
Finally, to show that the results were not affected by a
compensatory upregulation of E2F2 or E2F3, we evaluated the
levels of these transcription factors in control-siRNA- and
siE2F1-transfected 2F cells by qRT-PCR. As shown in Fig. 2E,
the absence of E2F1 does not impact on E2F2 or E2F3
expression. Collectively, these results indicate that E2F1
downregulation observed during ER stress is a necessary event
to execute the apoptotic programme.
Xbp-1 regulates the expression of E2F1 through E2F7 under
conditions of ER stress
To explore the mechanism(s) responsible for E2F1
transcriptional regulation under conditions of ER stress, we
evaluated the involvement of transcription factors known to
regulate the expression of this protein, such as E2F7 (Liu et al.,
Fig. 2. E2F1 downregulation and UPR or apoptosis response. (A,C) E2F1 expression was downregulated by RNAi (siE2F1#1 and #2) and E2F1 mRNA (left
panel) and protein (right panel) levels were revealed by qRT-PCR or western blotting analysis, respectively, in 2F (A) or SaOS-2 (C) cells. Scrambled oligo was
used as a negative control (siCtrl). Gapdh is shown as a protein loading control. Western blotting data are representative of experiments performed three times.
r.l., relative levels. (B,D) Cell death was measured by flow cytometric analysis at 24 h post-thapsigargin (TG) treatment under the same experimental conditions
in 2F (B) or SaOS-2 (D) cells, indicating an enhanced susceptibility of siE2F cells to thapsigargin treatment. (E) The expression level of E2F2 or E2F3 was
evaluated in both siCtrl and siE2F1 2F cells by qRT-PCR, revealing no compensative upregulation of either factor in the absence of E2F1. Quantitative data
show the mean6s.d. and are representative of three independent experiments performed in triplicate. *P,0.05, #P,0.05 (Student’s t-test).
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2013; Panagiotis Zalmas et al., 2008), together with those
activated under ER stress conditions, such as ATF6 (Haze et al.,
2001).
It is well established that E2F7 is able to control the
expression of E2F1 and, in turn, influence the ability of cells to
respond to DNA damage (Panagiotis Zalmas et al., 2008).
Thus, we evaluated the kinetics of expression of E2F7 in 2F
cells treated with thapsigargin or left untreated. This evaluation
was performed within 18 h of thapsigargin treatment,
corresponding to the time during which we observed a
Fig. 3. See next page for legend.
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collapse of E2F1 expression (Fig. 1I–K). As reported in
Fig. 3A, we observed a clear upregulation of E2F7 under
thapsigargin treatment, with a peak of expression at 4 h.
Therefore, to assess whether E2F7 binds to the E2F1 promoter
during ER stress response, we performed a chromatin
immunoprecipitation (ChIP) assay in 2F cells treated with
thapsigargin for 0, 6 and 10 h, using a specific anti-E2F7
antibody. As shown in Fig. 3B, we confirmed that E2F7 is
bound to the E2F1 promoter (t50) (Panagiotis Zalmas et al.,
2008); after thapsigargin exposure, we observed an initial
slight dissociation of E2F7 from the E2F1 promoter (6 h),
in line with a slight E2F1 mRNA upregulation reported in
Fig. 1J after 4 h of thapsigargin exposure, whereas we
registered a clear increased interaction between E2F7 and the
E2F1 promoter at 10 h of thapsigargin exposure, correlating
with the previously observed E2F1 expression decrease
(Fig. 1I–L).
We thus focused on E2F7 expression regulation under ER stress
conditions and performed a computational analysis of the E2F7
promoter region and identified the presence of a putative
responsive element (RE) site for Xbp-1 (2443 to 2438; Fig. 3D,
upper panel), a factor known to be upregulated early during the
UPR (Iwakoshi et al., 2003). We compared the kinetics of
expression of Xbp-1 and E2F7 within 4 h of thapsigargin exposure,
a time period corresponding to the peak of E2F7 expression, in 2F
cells. This analysis revealed that Xbp-1 upregulation precedes that
of E2F7, consistent with our hypothesis that Xpb-1 regulates the
expression of E2F7 during ER stress (Fig. 3C). ChIP analysis of
the E2F7 promoter with an anti-Xbp-1 antibody confirmed the
interaction between Xbp-1 and the putative RE on the E2F7
promoter during the UPR response (Fig. 3D).
To confirm that Xbp-1 is upstream of E2F7, we inhibited the
upregulation of Xbp-1 under ER stress conditions, by silencing the
expression of IRE1 (Fig. 3E). We observed a clear inhibition of
both Xbp-1 and E2F7 upregulation (Fig. 3F,G, respectively) in
thapsigargin-treated cells expressing short hairpin (sh)RNA against
IRE1 (shIRE1 cells), indicating that Xbp-1 is directly responsible
for E2F7 expression regulation under ER stress conditions that, in
turn, repress the expression of E2F1, as shown in Fig. 3H.
ATF6 is involved in E2F1 downregulation during ER
stress-mediated cell death
ATF6 is constitutively synthesised as a type II transmembrane
glycoprotein anchored to the ER membranes, and it is activated
by proteolysis in response to ER stress (Haze et al., 1999; Haze
et al., 2001). During the UPR, ATF6 translocates to the Golgi
where is cleaved by site-1 (S1P) and site-2 (S2P) proteases (Ye
et al., 2000). The N-terminal fragment (active form of ATF6) is
thereby released from the membrane, enters the nucleus and
interacts with target gene promoters by direct binding to a
mammalian ER stress response element (ERSE) (Yoshida et al.,
2000; Yoshida et al., 2001).
In order to evaluate the potential role of ATF6 in the E2F1
downregulation during ER stress-mediated apoptosis, we inhibited
ATF6 activation using the serine protease inhibitor AEBSF [4-(2-
aminoethyl)benzenesulfonyl fluoride] and evaluated E2F1 mRNA
and protein levels after thapsigargin treatment, by qRT-PCR and
western blotting analysis, respectively. AEBSF (Okada et al.,
2003) inhibited the ER stress-induced proteolysis of ATF6, thus
preventing its transcriptional activity, as demonstrated by the
inhibition of both its self-upregulation (Fig. 4A, left panel) and
upregulation of its main target Grp78 (Fig. 4A, middle panel).
Interestingly, as shown in Fig. 4A (right panel) and Fig. 4B,
AEBSF impaired the ER stress-mediated decrease in E2F1
expression at both mRNA (TG 18 h – 85% E2F1 repression,
compared to 50% repression in the presence of AEBSF) and
protein levels (TG 18 h – 90% E2F1 repression, compared to 40%
repression in the presence of AEBSF). Moreover, the presence of
AEBSF was also accompanied by a significant reduction in
thapsigargin-induced cell death (Fig. 4C; TG – 24% apoptosis,
compared to 14% in TG+AEBSF treated cells), indicating a
potential direct correlation between the ER-stress-induced ATF6-
mediated cell death and E2F1 downregulation.
To gain additional support for the direct role of ATF6 in the
regulation of E2F1 expression during UPR-mediated cell death, a
computational analysis of the E2F1 promoter region was
performed and a putative ERSE site for ATF6 binding (264 to
245) was identified (Fig. 4E, upper panel) close to the two
known regulative E2F REs (E2F-A and E2F-B) (Araki et al.,
2003). Therefore, a ChIP assay was performed using an ATF6-
specific antibody. As shown in Fig. 4D, ATF6 binds to the E2F1
promoter after thapsigargin treatment in a time-dependent
manner, thus correlating with the E2F1 mRNA decrease
observed during thapsigargin treatment (Fig. 1J).
To further characterise the role of the putative ERSE
sequence in the control of E2F1 expression, this site was
mutated in a reporter plasmid carrying the luciferase gene
under the control of the human E2F1 promoter containing the
region 242 bp upstream of the transcription initiation site
(ERSE-Mut; Fig. 4E, lower panel) (Araki et al., 2003). The
wild-type ERSE (ERSE-WT) or ERSE-Mut E2F1 luciferase
promoter constructs were transiently transfected into 2F cells,
and luciferase reporter activity was analysed either before or
8 h after thapsigargin exposure. As reported in Fig. 4F,
mutation of the ERSE site resulted in higher basal activity of
the ATF6 promoter compared to that observed with ERSE-WT,
and enhanced rather than decreased the activity of the promoter
after thapsigargin exposure, completely abrogating the
repression from ATF6. Combined with the ChIP analysis,
these data confirm that active ATF6 binds to the ERSE motif
on the E2F1 promoter, thus repressing the expression of E2F1
during UPR.
Fig. 3. E2F7 contributes to E2F1 downregulation under conditions of
ER stress. (A) 2F cells were treated with thapsigargin (TG) as indicated and
qRT-PCR analysis shows the upregulation of E2F7. r.l., relative levels.
(B) ChIP analysis of E2F7 transcription factor binding to the E2F1 promoter
reveals an enhanced interaction at 10 h post-thapsigargin treatment. Left
panel, representative analysis of an experiment performed three times.
INPUT, total DNA. IP, immunoprecipitation. Right panel, graph showing
densitometric analysis of three independent experiments. (C) The expression
patterns of E2F7 and Xpb-1 were monitored in thapsigargin-exposed 2F cells
by qRT-PCR, indicating an earlier upregulation of Xbp-1 compared with that
of E2F7. (D) Schematic representation of the putative Xbp-1 responsive
element (RE) in the E2F7 promoter region (upper panel). ChIP analysis of
Xbp-1 transcription factor binding to the E2F7 promoter was evaluated (lower
panel), indicating an enhanced interaction 6 h post-thapsigargin treatment.
Lower left panel, representative analysis of an experiment performed three
times. Lower right panel, graph showing densitometric analysis of three
independent experiments. (E) 2F cells were infected with lentiviral particles
carrying a specific shRNA for IRE1 (shIRE1#28), and the expression of IRE1
was evaluated by qRT-PCR. (F–H) 2F cells in E were treated with
thapsigargin or left untreated, and Xbp-1 (F), E2F7 (G) or E2F1
(H) expression was evaluated by qRT-PCR analysis, showing an inhibited
thapsigargin-dependent upregulation of all factors in shIRE1 cells compared
with shCtrl ones. All quantitative data show the mean6s.d. and are
representative of three independent experiments performed in triplicate.
*P,0.05, #P,0.05 (Student’s t-test).
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Finally, to confirm that both E2F7 and ATF6 are concomitantly
involved in the transcriptional repression of E2F1 under ER stress
conditions, we transiently overexpressed E2F7 and active ATF6
either alone or in combination and evaluated the levels of E2F1
protein. As shown in Fig. 4G, E2F7 and active ATF6 were found
to downregulate the expression of E2F1 when expressed
Fig. 4. See next page for legend.
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separately, whereas their coexpression resulted in complete
abrogation of E2F1 expression. Collectively, these data indicate
that ER-stress-mediated E2F7 upregulation and ATF6 activation
are responsible for E2F1 transcriptional repression (Fig. 4H).
Downregulation of E2F1 does not affect the UPR
To further elucidate the role of E2F1 downregulation during ER
stress-mediated apoptosis, we monitored the induction of the
UPR by measuring the expression of key markers in thapsigargin-
treated cells upon silencing of E2F1. Our results showed that
E2F1 knockdown only slightly increases the capacity of the cell
to mount an UPR under conditions of ER perturbation. In fact,
thapsigargin treatment (4 h) of siE2F1 cells resulted in a modest
increase in the levels of the analysed ER stress markers compared
with those of the siCtrl cells – these markers included ERp57
(also known as PDIA1; Fig. 5A, upper left panel) (Frickel et al.,
2004), ERdj5 (also known as DNAJC10; Fig. 5A, upper right
panel) (Cunnea et al., 2003) and Xbp-1 (Fig. 5A, lower left panel)
(Iwakoshi et al., 2003). It also resulted in enhanced Gadd153
(also known as DDIT3) expression (Fig. 5A, lower right panel)
(Wang et al., 1996), possibly owing to the removal of known
repression exerted by E2F1 on Gadd153 expression (Pan et al.,
2010).
Given that E2F1 regulates the expression of pro-apoptotic
BH3-only proteins during DNA-damage-induced cell death
(Hershko and Ginsberg, 2004), we asked whether its
downregulation could have had an influence on the regulation
of Noxa and Puma under ER stress conditions. To this aim, we
evaluated the mRNA levels of Puma and Noxa in 2F cells in
which the expression of E2F1 was impaired by transient
transfection of specific siRNA. As shown in Fig. 5B, the
absence of E2F1 did not prevent the upregulation of these
BH3-only proteins under ER stress conditions but, unexpectedly,
it resulted in an increase in the expression levels of both Noxa and
Puma, which could explain the enhanced susceptibility of these
cells to apoptosis induction (Fig. 2), and possibly indicates that
this factor negatively regulates the transcription of both of the
BH3-only proteins.
These data also indicate that E2F1 and ATF4 might regulate
the expression of these proteins at different levels. To
demonstrate the independent regulation of the two BH3-only
proteins by ATF4 and E2F1, 2F cells were transiently transfected
with specific siRNA oligos for ATF4 or E2F1 individually or
concomitantly, and the expression of Puma and Noxa was
evaluated in the presence or absence of thapsigargin (4 h). As
shown in Fig. 5C, (1) the absence of E2F1 per se confirmed
enhanced basal expression of the two proteins but did not affect
their thapsigargin-mediated upregulation, (2) the silencing of
ATF4 abrogated the thapsigargin-mediated upregulation of both
Puma and Noxa but did not affect their basal expression and,
finally, (3) the concomitant absence of both E2F1 and ATF4
resulted in both enhanced basal expression and inhibition of
thapsigargin-mediated expression of the two BH3-only pro-
apoptotic proteins, indicating that Noxa and Puma are
independently regulated by E2F1 and ATF4.
E2F1 expression is inhibited at the point of no return of the
life/death switch during the ER stress response
Timely downregulation of E2F1 in advanced stages of the UPR
could be required for the switch from the pro-survival to pro-
death programme. To test this hypothesis, we evaluated the
expression pattern of the main pro-apoptotic and anti-apoptotic
actors of this process, in 2F cells exposed to thapsigargin in a
timecourse experiment (0–18 h). As reported in Fig. 6A, we
confirmed the upregulation of both E2F7 and ATF6 after
thapsigargin exposure, highlighting an overlapping pattern
of expression after 6 h of treatment, a time when E2F1 levels
start to decrease, further confirming their cooperation in the
transcriptional repression of E2F1. The early ATF4-mediated
upregulation of Noxa and Puma (2–6 h) is followed by a sharp
decrease in their expression until E2F1 is downregulated, after
which the expression of Noxa and Puma remains constant until
the end of the treatment (compare Fig. 6B,C). In parallel, we also
observed an early increased expression of the pro-apoptotic
factors Bax, Gadd153 and TRB3 (also known as TRIB3)
(Fig. 6D), whereas expression of anti-apoptotic Bcl-2 decreased
after 6–8 h of thapsigargin exposure (Fig. 6E, left panel). Similar
to Puma and Noxa, the early upregulation of Bax, Gadd53 and
TRB3 (2–6 h) is followed by a decrease in their expression until
E2F1 is downregulated, after which their expression remains
constant until the end of the treatment. This is particularly true for
Bax and Gadd53. Moreover, the initially increased level of the
anti-apoptotic Mcl-1 (Fig. 6E, right panel), which is induced by
ATF4 – as shown by the lack of upregulation in absence of this
transcription factor (Fig. 6F) – returned to basal levels after 6–8 h
of thapsigargin exposure.
Finally, we performed a treatment and recovery experiment in
which 2F cells were exposed to tunicamycin for the indicated
Fig. 4. ATF6 contribution to E2F1 gene expression regulation during ER
stress. (A) 2F cells were pre-treated for 1 h with AEBSF and exposed to
thapsigargin (TG), as indicated. ATF6 (left panel), Grp78 (middle panel) or
E2F1 (right panel) expression levels were evaluated by qRT-PCR, showing
an inhibited thapsigargin-induced upregulation of both ATF6 and Grp78, and
a decreased repression of E2F1, in the presence of AEBSF. r.l., relative
levels. (B,C) E2F1 protein levels were measured by western blotting analysis
in the presence or absence of both thapsigargin and AEBSF as indicated
(B), confirming results reported in A. Western blotting data are from a
representative experiment performed three times. Cell death was evaluated
under the same experimental condition at 24 h post-treatment, by flow
cytometric analysis (C), revealing a partial inhibition of thapsigargin-induced
cell death in the presence of AEBSF. (D) ChIP analysis was performed to
verify the binding of ATF6 to the E2F1 promoter. Results indicate a time-
dependent increase in ATF6 binding to E2F1 promoter. Left panel,
representative analysis of an experiment performed three times. INPUT, total
DNA. IP, immunoprecipitation. Right panel, graph showing densitometric
analysis of three independent experiments. (E) Schematic representation of
the ERSE responsive element (RE) (ERSE, upper panel) and the mutant
(ERSE Mut, lower panel) in the E2F1 promoter region. The E2F binding sites
(RE) are also indicated (E2F-A and E2F-B). (F) Renilla and luciferase
constructs containing the E2F1 promoters carrying the putative ATF6-binding
site wild-type (ERSE-WT) or mutant (ERSE-MUT) were co-transfected into
2F cells. Cells were treated for 8 h with thapsigargin or left untreated as
indicated. The luciferase assay reveals an abrogated ATF6-dependent
repression of the E2F1 promoter. Relative luciferase units (RLU), normalised
to Renilla, are shown as a percentage of the control (untreated cells). (G) 2F
cells were transiently transfected with plasmids encoding Flag–E2F7 and/or
HA–ATF6(373), and protein levels of E2F1, E2F7 or ATF6 were evaluated by
western blotting analysis, revealing a complete repression of E2F1
expression in cells overexpressing both ATF6 and E2F7. (H) Schematic
representation of the E2F1 promoter region carrying the ATF6 (ERSE) and
E2F7 (E2F-A) binding sites. The question mark indicates a possible direct or
indirect cooperative interaction between ATF6 and E2F7. All quantitative
data show the mean6s.d. and are representative of three independent
experiments performed in triplicate. *P,0.05, #P,0.05 (Student’s t-test). In
A, the asterisk (*) refers to AEBSF+TG compared to thapsigargin alone after
8 h, whereas the hash (#) refers to AEBSF+TG compared to thapsigargin
alone after 18 h.
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Fig. 5. See next page for legend.
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time, then tunicamycin was removed and the cells were allowed
to recover in culture until 24 h. Tunicamycin was used rather than
thapsigargin because of its reversible effects on ER. We then
evaluated both the induction of apoptosis (0–24 h) and mRNA
levels of E2F1 (0–18 h), by flow cytometric analysis of
propidium-iodide-stained cells or by qRT-PCR, respectively. As
reported in Fig. 6G, we observed a complete cell recovery from
ER stress between 0 and 8 h of tunicamycin treatment, whereas
progressive apoptosis induction was observed after 10 h of
tunicamycin exposure, paralleled by a progressive and dramatic
E2F1 downregulation. Overall, these data support the hypothesis
that the regulation of levels of anti-apoptotic versus pro-apoptotic
factors during the UPR is responsible for the life/death cell
decision. In this context, the inhibition of E2F1 expression during
sustained ER stress contributes to the induction of apoptosis by
regulating the expression of pro-apoptotic BH3-only proteins.
DISCUSSION
The ER represents a compartment that is able to sense several
cellular stresses and, as a last resort, to trigger cell death
(Rutkowski and Kaufman, 2004). However, the ER stress
condition primarily represents a pro-survival cell response,
resulting in the activation of a number of adaptive responses,
collectively termed the UPR, to bring the cell back to
homeostasis. In fact, the UPR inhibits pro-death signals unless
the stimulation is prolonged and/or the damage exceeds the
adaptive response, resulting in the induction of apoptosis
(Verfaillie et al., 2013; Walter and Ron, 2011).
However, many human cancers show alterations in the UPR,
allowing them to adapt to chronic stress to avoid cell death.
Therefore, components of the UPR might represent a useful
therapeutic target for cancer therapies. Thus, understanding the
molecular mechanisms regulating the life/death response switch
under conditions of ER stress is essential to allow the
identification of novel strategies to overcome cancer cell death
resistance.
Here, we show that two key events contribute to an efficient
induction and execution of ER-stress-mediated cell death: (1) the
upregulation of pro-apoptotic BH3-only family members Noxa and
Puma and (2) the downregulation of the transcription factor E2F1.
We found that, under ER stress conditions, ATF4, one of the
early transcription factors activated during the UPR, upregulates
Noxa and Puma at both the mRNA and protein level. The key role
of these players is shown by the fact that both their direct
silencing or that of ATF4 results in a strong inhibition of ER-
stress-mediated cell death. The residual level of apoptosis
observed in the absence of these BH3-only proteins suggests
that other ER stress-activated pro-apoptotic factors might be
involved in this pathway, such as Bim (Puthalakath et al., 2007).
These results are in line with data recently reported by Qing and
colleagues, showing that glutamine deprivation induces apoptosis
in Myc-overexpressing neuroblastoma cells through ATF4-
dependent Puma and Noxa upregulation (Qing et al., 2012).
It is important to note that, although the pro-apoptotic
signalling involving ATF4, Puma and Noxa is an early-
activated system (2–4 h after the stimulus), the execution phase
of the apoptotic pathway is a later event (18 h after stimulus),
suggesting that a secondary signal is required to switch between
the pro-survival and pro-death response. Indeed, at variance with
those apoptotic pathways in which E2F1 expression is required
for their execution, unexpectedly, we found that E2F1 levels
decrease during ER-stress-mediated apoptosis, and that this
downregulation importantly contributes to the time-regulated
execution of the cell death pathway.
E2F1 is known to exert different effects on cell growth and
apoptosis depending on the cell context. During cell cycle
progression, transient activation of E2F1 promotes cell growth
by driving the G1 to S phase transition, under the control of
pRb, whereas its deregulated activity leads to uncontrolled
cell proliferation, a hallmark of cancer. Interestingly, E2F1
activation and upregulation following DNA damage induces a
cell death response by both upregulating pro-apoptotic genes and
inhibiting anti-apoptotic survival signals (Blattner et al., 1999;
Ginsberg, 2002; Stanelle and Pu¨tzer, 2006) in a p53-dependent
and -independent manner (Croxton et al., 2002; Eischen et al.,
2001).
Analysis of the E2F1 expression pattern during the UPR
suggests that its downregulation is a result of specific
transcriptional repression. Moreover, siRNA-mediated E2F1
downregulation increases the amount of cell death in response
to ER stress, indicating that the phenomenon is not merely a
consequence of UPR execution, but represents a prerequisite to
efficiently induce the ER-stress-mediated death pathway. In this
context, E2F1 might thus control the switch between the two ER
stress branches – the pro-survival and pro-apoptotic one. In fact,
E2F1 knockdown results in enhanced basal expression of Noxa
and Puma, but not in cell death induction per se.
Collectively, these data suggest that, under ER stress
conditions, the expression of Puma, Noxa and Gadd153 is
promptly induced by ATF4 as an early event, together with the
upregulation of pro-survival factors (such as Mcl-1), so that anti-
apoptotic signals will keep pro-apoptotic ones at bay to ensure the
initial survival activity of UPR. However, prolonged ER stress
leads inevitably to cell death, a condition requiring a secondary
signal to switch from pro-survival to pro-death UPR pathways. In
fact, although sustained ER stress results in an initial decline in
ATF4, Puma, Noxa and Gadd153 expression, the specific
repression of E2F1 transcription, coinciding with the point of
no return as evidenced by the induction of apoptosis, is associated
with a new sustained expression of the above-mentioned pro-
apoptotic factors together with the downregulation of anti-
apoptotic proteins, such as Bcl-2 and Mcl-1. Although the
inhibition of Mcl-1 expression is a direct consequence of ATF4
inactivation (Hu et al., 2012), the transcriptional repression of
Bcl-2 is a result of Gadd153 activity that, free from its negative
regulator (Ohoka et al., 2005), might contribute to the induction
of the pro-death pathway. The contribution of E2F1 to the control
of the UPR life-to-death switch is also corroborated by our data
Fig. 5. E2F1 does not interfere with the UPR and controls Puma and
Noxa expression independently of ATF4. (A) E2F1 expression was
downregulated in 2F cells by RNAi and mRNA levels of ERp57, ERdj5, Xbp-
1 or Gadd153 were evaluated by qRT-PCR in treated [thapsgargin (TG), 4 h]
or untreated cells, indicating no significant change in their expression, except
for Gadd153. r.l., relative levels. (B) Levels of Noxa (left panel) or Puma (right
panel) mRNA were also evaluated after thapsigargin exposure, as indicated,
under the same experimental conditions as in A. (C) E2F1 and/or ATF4
expression were downregulated in 2F cells by RNAi, and mRNA levels of
Noxa (left panel) or Puma (right panel) were evaluated by qRT-PCR in
thapsigargin-treated (4 h) or untreated cells, indicating no overlapping
signalling. All data show the mean6s.d. and are representative of three
independent experiments performed in triplicate. *P,0.05, #P,0.05,
§P,0.05, $P,0.05 (Student’s t-test). In C, *siE2F12TG compared to
siCtrl2TG; #siATF4+TG compared to siCtrl+TG; §siATF4/siE2F12TG
compared to siCtrl2TG; $siATF4/siE2F1+TG compared to siCtrl+TG.
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Fig. 6. See next page for legend.
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showing decreased cell death induction if the downregulation of
E2F1 is inhibited.
Our hypothesis is also supported by recent evidence that shows
that the activity of E2F1 might affect the ER stress response by
inhibiting the expression of the ER master chaperone Grp78
(Racek et al., 2008), together with the identification of E2F1 as a
transcriptional regulator of autophagy, a typical pro-survival
stress response (Polager et al., 2008; Wang et al., 2010). Thus,
owing to the close link existing between ER stress, autophagy and
apoptosis induction, and the reported evidence establishing that
reduction of E2F1 expression inhibits stress-induced autophagy
(Polager et al., 2008), it is conceivable that ER-stress-mediated
E2F1 downregulation might contribute to the life/death cell
decision under prolonged ER stress.
In contrast to our results, Park and collaborators observed that
E2F12/2 murine embryonic fibroblast (MEF) cells are resistant to
apoptosis triggered by ER stress (Park et al., 2006). A possible
explanation for such contrasting data might reside in the
experimental model used to inhibit the expression of E2F1.
Indeed, RNAi represents a means of acute gene silencing,
whereas the gene knockout is, instead, a chronic state that can
give rise to issues of adaptation or compensation.
Furthermore, we identified ATF6 and E2F7 to be responsible for
the tuning of E2F1 expression during UPR. We demonstrated that
ATF6 controls the expression of E2F1 during the UPR through
direct binding to an ERSE site within the E2F1 gene promoter. To
our knowledge, this is the first evidence of repressor activity for
ATF6 during the ER-stress-mediated cell death programme.
Indeed, besides the well-established positive transcriptional
activity of ATF6 exerted during the UPR programme, it is now
becoming evident that ATF6 might also repress the transcription of
some target genes, such as CFTR, probably interacting with other
transcription factors (Bartoszewski et al., 2008).
We also found that E2F7, a known transcription factor regulating
E2F1 expression, is involved in the ER-stress-mediated
downregulation of E2F1. We identified the IRE1–Xbp-1 UPR
axes responsible for direct E2F7 early upregulation during the ER
stress response, thus modulating, in turn, the expression of E2F1.
The kinetics of interaction of both E2F7 and active ATF6 with
the E2F1 promoter correlate with the transcriptional repression of
E2F1. The close proximity of the two responsive elements, ERSE
and E2F-A, suggests that ATF6 and E2F7 might work in a
coordinated way, possibly by direct interaction or requiring
additional partners.
Collectively, our data indicate that disruption of ER stress
homeostasis, coupled to E2F1 gene expression modulation, might
represent a new valuable target for the development of novel
therapeutic strategies against chemoresistant tumour malignancies.
In this respect, it is conceivable that tumour cells could be treated
with a combination of compounds able to negatively regulate the
expression or activity of E2F1, such as eugenol (Ghosh et al., 2005)
or CDK4/6 inhibitors (Zhussupova et al., 2014), plus compounds
triggering an ER-stress-mediated apoptotic process, such as
fenretinide (Corazzari et al., 2007).
MATERIALS AND METHODS
Cell culture and flow cytometry
The human fibroblastic 2FTGH (2F), osteosarcoma (SaOs-2) and
melanoma (CHL-1) cell lines were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal
bovine serum (FBS, Sigma-Aldrich), 2 mM L-glutamine (Sigma-
Aldrich) and 1% penicillin-streptomycin solution (Sigma-Aldrich) at
37 C˚ under 5% CO2. Cells were treated with 10 mg/ml thapsigargin
(Sigma-Aldrich), 10 mg/ml tunicamycin (Sigma-Aldrich) or 10 mg/ml
etoposide (Sigma-Aldrich) in DMSO, with an equal volume of vehicle
used to treated control cells. AEBSF (Sigma-Aldrich) was added to a
final concentration of 500 mM. Flow cytometry of fixed and propidium-
iodide-stained cells was used to estimate the level of cell death by
measuring the percentage of cells in the sub-G1 fraction as described
previously (Corazzari et al., 2003).
RNA interference
siRNA oligoribonucleotides corresponding to the indicated human cDNAs
were purchased as follows: E2F1, E2F7 and Puma from Invitrogen, ATF4
from Qiagen, Noxa from Dharmacon. Non-targeting scrambled siRNA
(siCtrl) was used as the negative control. shRNA vectors corresponding to
the human IRE1 cDNA were purchased from Invitrogen. A non-targeting
shRNA with a scrambled targeting sequence (shCtrl) was used as the
negative control. A total of 256104 cells/well were transfected with
100 pmol siRNA in six-well plates by using RNAi Max (Invitrogen) as
recommended by the supplier. Transfection was repeated on two consecutive
days to increase transfection efficiency. At 24 h after transfection, cells were
trypsinised, plated at 306104 cells/well in six-well plates and treated with the
indicated agents. RNA was checked by quantitative RT-PCR (qRT-PCR)
and western blotting analysis at 48 h after transfection.
Cell transfection
Flag–E2F7 was kindly provided by Dr Nicholas B. La Thangue
(Panagiotis Zalmas et al., 2008), whereas HA-ATF6(1-373) was
purchased from Addgene (plasmid 27173, from Dr Yan Wang) (Wang
et al., 2000). A total of 256104 cells/well were transfected with 1 mg of
total DNA in six-well plates by using Lipofectamine LTX (Invitrogen)
for 8 h, as recommended by the supplier. At 24 h after transfection, cells
were trypsinised, plated at 306104 cells/well in six-well plates and
treated as indicated.
Lentivirus generation and infection
To generate lentivirus, 10 mg of the lentiviral vectors (shRNA-pLKO)
were co-transfected with 2.5 mg of an expression plasmid for the
vesicular stomatitis virus G protein and psPAX2 plasmid, containing gag,
pol and rev genes, into a 293T packaging cell line by using the calcium
phosphate method. At 48 h later, the supernatant containing the lentiviral
particles was recovered and supplemented with polybrene (4 mg/ml).
Cells were infected by incubation with lentiviral-containing supernatant
for 6–8 h.
qRT-PCR
RNA was extracted by using Trizol reagent (Invitrogen). cDNA synthesis
was performed using the reverse transcription kit (Promega) according
to the manufacturer’s recommendations. Quantitative PCR reactions
were performed with the Rotor-Gene 6000 (Corbett Life Science)
thermocycler. The Maxima SYBR Green/ROX qPCR Master Mix
(Thermo Scientific) was used to produce fluorescently labeled PCR
Fig. 6. E2F1 modulation contributes to life/death cell decisions under
ER stress conditions. (A–E) 2F cells were exposed to thapsigargin (TG) as
indicated (0–18 h), and expression of E2F7 and ATF6 (A), Puma and Noxa
(B), ATF4 and E2F1 (C), Bax, Gadd53 and TRB3 (D), Bcl-2 and Mcl-1
(E) were evaluated at each time-point by qRT-PCR. r.l., relative levels. (F) 2F
cells were transiently transfected with two siRNA oligos to downregulate the
expression of ATF4 (siATF4#5 and #9) and were treated with thapsigargin for
5 h or left untreated. The expression level of Mcl-1 was evaluated by qRT-
PCR. Scrambled oligo was used as a negative control (siCtrl). (G) For the
exposure/recovery experiment, 2F cells were exposed to tunicamycin (TN);
at each time-point, tunicamycin was removed and cells were maintained in
culture for a total of 24 h; expression of E2F1 (dotted line) and apoptosis
induction (solid line) were evaluated by qRT-PCR or flow cytometry,
respectively. The results indicate an increased apoptosis induction
concomitant to E2F1 downregulation. All data show the mean6s.d. and are
representative of three independent experiments performed in triplicate.
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products during repetitive cycling of the amplification reaction and the
melting curve protocol was used to check for probe specificity as
described previously (Corazzari et al., 2007). Primer sets for all
amplicons were designed using the Primer-Express 1.0 software system
and are reported in supplementary material Table S1.
The result of the fluorescent PCR was expressed as the threshold cycle
(CT). The DCT is the difference between the CT for the specific mRNA
and the CT for the reference mRNA, L34. To determine relative mRNA
levels, 2 was raised to the power of DDCT (the difference between the
DCT from treated cells and the CT from untreated cells). L34 mRNA
level was used as an internal control because this gene was shown to be
stable with cell induction (Corazzari et al., 2007).
Western blotting
Total proteins were extracted from cells by using the cell lytic buffer
(Sigma-Aldrich), resolved by electrophoresis through 10% SDS-PAGE
gels (10–20 mg per line) and electroblotted onto nitrocellulose membrane
(Protran, Schleicher and Schuell). Blots were incubated with the
indicated primary antibodies (supplementary material Table S2) in 5%
non-fat dry milk in PBS plus 0.1% Tween-20 overnight at 4 C˚. Detection
was achieved using horseradish-peroxidase-conjugated secondary
antibody (1:5000; Jackson ImmunoResearch) and blots were visualised
with ECL plus (Amersham Bioscience).
ChIP assay
2F cells (36107/treatment) were treated with 10 mg/ml thapsigargin for 6
or 10 h, then crosslinked in 1% formaldehyde for 10 min at room
temperature and quenched with 125 mM glycine for 5 min. Cells were
washed twice with PBS, sonicated for 30 min (Diagenode, Belgium, 30-s
pulses, 30-s rests) and immunoprecipitated with magnetic beads and
8 mg of primary antibody (Abcam mouse monoclonal antibody against
ATF6 or Santa Cruz Biotechnology rabbit polyclonal antibody against
XBP-1) overnight at 4 C˚ with rotation. Next, complexes were eluted,
sequentially washed in low salt buffer, LiCl buffer and TE buffer (5 min
each, with rotation), then incubated with 0.5 mg/ml Proteinase K at 50 C˚
for 3 h with rotation. Eluted DNA was purified and subjected to PCR
analysis with primers directed against the E2F1 or E2F7 promoter
(supplementary material Table S3). PCR products (E2F1, 124 bp; E2F7,
120 bp) were resolved on 2% agarose gels.
ERSE mutant
The human wild-type E2F1 promoter reporter plasmid [E2F1-Luc
(2242)] was kindly provided by Prof. Masa-Aki Ikeda (Araki et al.,
2003). Mutations in the putative ERSE sequence on the E2F1 promoter
region of the wild-type E2F1-Luc (2242) were introduced by site-
directed mutagenesis. A primer set carrying mutations of the putative
ERSE sequence, introducing restriction sites for NheI and XhoI, was used
to amplify the E2F1-Luc vector, using Pfu DNA polymerase (Pomega)
(supplementary material Table S4). After amplification, DpnI was used to
degrade the wild-type vector. XhoI or NheI digestion and vector
sequencing were used to identify positive mutants.
Luciferase assay
For the luciferase assay, 2 mg of pGL2-E2F1-Promoter [ERSE-WT or
pGL2-E2F1(ERSE-Mut)-Promoter (ERSE-Mut)] was transiently co-
transfected together with 0.2 mg of Renilla luciferase vector into
2.56105 2F cells using Lipofectamine LTX as indicated by the supplier
(Invitrogen). At 24 h post-transfection, 96104 cells were plated in a 12-
well plate and treated for 8 h with 10 mg/ml thapsigargin or left
untreated. Firefly and Renilla luciferase were quantified by using the
Dual Luciferase Reporter Assay System (Promega) as indicated by the
supplier. All assays were performed at least three times in quadruplicate
and independently.
Promoter analysis
The identification of putative transcription factor binding sites (TFBS) in
E2F7 and E2F1 promoter DNA sequences was performed by using
MatInspector software (Genomatix).
Statistical analysis
All experiments were performed at least three times. All data reported are
representative of three independent experiments performed in triplicate;
western blotting and ChIP images are from a representative experiment
performed three times. GraphPad Prism 5 was used for statistical
analysis. Statistical significance was determined using the Student’s t-
test. A P-value of equal to or less than 0.05 was considered significant.
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